These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 20231208
1. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF. J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208 [Abstract] [Full Text] [Related]
2. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M. Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123 [Abstract] [Full Text] [Related]
6. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F. Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665 [Abstract] [Full Text] [Related]
7. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM. Takato H, Waseda Y, Watanabe S, Inuzuka K, Katayama N, Ichikawa Y, Yasui M, Fujimura M. Respir Med; 2013 Jan 01; 107(1):128-33. PubMed ID: 23137883 [Abstract] [Full Text] [Related]
8. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T. PLoS One; 2015 Jan 01; 10(3):e0120313. PubMed ID: 25789468 [Abstract] [Full Text] [Related]
9. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S. J Med Invest; 2018 Jan 01; 65(3.4):251-257. PubMed ID: 30282869 [Abstract] [Full Text] [Related]
10. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease. Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T. Respir Investig; 2017 Jan 01; 55(1):24-32. PubMed ID: 28012490 [Abstract] [Full Text] [Related]
11. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies. Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K. J Dermatol; 2019 Oct 01; 46(10):886-897. PubMed ID: 31418479 [Abstract] [Full Text] [Related]
19. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q. BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248 [Abstract] [Full Text] [Related]